Cerus Endovascular raises £1.5m from Spark Impact

The vehicle, managed by Spark Impact on behalf of the £155m North West Fund, committed £600,000 to Cerus.

Life-sciences angel group Mid Atlantic Bio Angels participated in the round with a $500,000 capital injection.

The firm will use the funds to boost product development and accelerate pre-clinical trials prior to CE marking approval.

Company
Cerus is engaged in the design and development of interventional neuro-radiology devices and delivery systems for the treatment of neurovascular diseases. The firm is particularly focused on intracranial aneurysms through the use of an aneurysm occlusive device. Devices and systems are designed to be minimally invasive.

The company is headquartered in Oxford but will soon move to the Liverpool Science Park and was founded in 2011.

People
Penny Attridge is a senior investment director at Spark Impact and manages the North West Fund for Biomedical.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare
• Early-stage
• United Kingdom